Zacks Investment Research
20 Mar 2026, 12:55 UTC · 26w ago
Verdict
Headline takes no side. We score MCK +0.90 across five claims — strongly bullish.
+0.90strongly bullish
More positive than 94% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
McKesson reported 11% revenue growth and 13% operating profit growth for its third-quarter fiscal 2026.
More positive than 92% of claims this week
GLP-1 therapy revenues rose 26% year over year to $14 billion.
So whatGrowth in high-demand, high-value specialty drugs like GLP-1s provides a structural tailwind for future revenue and margins.
Continue reading
5 related stories
Seeking Alpha
6h ago
GlobeNewsWire
27m ago
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 85% of claims this week
Oncology and multispecialty revenues increased by 37%.
So whatSignificant acceleration in high-growth healthcare verticals reduces reliance on lower-margin core pharmaceutical distribution.
More positive than 76% of claims this week
McKesson forecasts 17.9% growth for the full year 2026.
So whatPositive forward guidance suggests management expects current momentum to sustain through the fiscal year.
More positive than 62% of claims this week
The company continues to face margin pressures and segment-level volatility.
So whatThese headwinds act as a ceiling on potential valuation expansion despite strong revenue growth.
More negative than 71% of claims this week
Which stocks this story touches
More positive than 94% of ticker scores this week
Reported strong third-quarter results with robust growth in specialty distribution and oncology services, exceeding earnings estimates.
More positive than 37% of relationship scores this week
[mutual] Both are leading pharmaceutical distributors listed together in a market comparison context.
More positive than 37% of relationship scores this week
[mutual] Both are leading pharmaceutical distributors listed together in a market comparison context.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−0.9%
Price is moving against the score
$891.23 vs $898.95 close before publication (Mar 19) · not market-adjusted
MCK chart →